2.5.1.2. Section 2: Threat Summary.

2.5.1.2.1. The purpose of this section is to provide context for the CRs addressed or enabled by the Joint DCR, to provide appropriate traceability to the approved threat products from DIE used during refinement of the capability requirements, and to describe updates to the threat products since validation of the requirements. When applicable, this information also enables threat assessment as part of the intelligence certification provided during Joint DCR review and validation, and facilitates rapid review and update of successor documents when applicable threat products are updated.

2.5.1.2.2. A threat summary is not applicable to all Joint DCRs depending upon the nature of the change recommendations. The Sponsor should coordinate with the proponent for the intelligence certificate, as outlined in Annex G to Appendix G of this enclosure, to determine whether or not a threat summary is required.

2.5.2.2.1. While many Joint DCRs do not require threat assessment or intelligence certification, some may be driven by changes to the threat environment or may propose DOTmLPF-P changes that affect intelligence supportability of fielded capability solutions. In addition, some Joint DCRs may be focused specifically on intelligence activities or fielded capability solutions. In these cases, an intelligence certification generally will be required.

2.5.1.2.2.2. Sponsors ensure all intelligence support requirements are identified in terms of the broad descriptions of categories described in Annex G to Appendix G of this enclosure, and included in the Joint DCR Operational Context, Capability Discussion, and Implementation Plans sections.

2.5.1.2.3. If the Joint DCR is a successor document to one or more validated requirement documents:

2.5.1.2.3.1. Cite the latest DIE approved threat products applicable to the capability requirements addressed or enabled by the Joint DCR. Ensure the applicable threat products reflect the most current analysis and findings related to evolving threats.

2.5.1.2.3.1.1. For Joint DCRs enabling or associated MDAPS, ensure the most current DIA-approved threat products are used to develop the Joint DCR and any associated studies or analysis.

2.5.1.2.3.1.2. For all other Joint DCRs where threat products are applicable, ensure the most current DIE approved threat products are used to develop the Joint DCR and any associated studies or analysis.

2.5.1.2.3.2. From the source document(s), outline the threat summary(ies) associated with the validated requirements addressed or enabled by the Joint DCR.

2.5.1.2.4. If the Joint DCR is not based on a validated requirements document, provide the threat summary as outlined for Section 2 of an ICD, as per Appendix A to this enclosure.